{"id":"W2313622309","doi":"10.1136/annrheumdis-2014-eular.2283","title":"SAT0396 Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-Year Results from A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Ustekinumab; Psoriatic arthritis; Adverse effect; Internal medicine; Concomitant; Placebo; Clinical endpoint; Randomization; Dosing; Psoriasis; Randomized controlled trial; Arthritis; Rheumatoid arthritis; Adalimumab; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00262621,0.001543531,0.004165257,0.0005258544,0.0006188184,0.001254409,0.001030221,0.002072799,0.003173757],"category_scores_gemma":[0.001553856,0.0007261245,0.003185423,0.0007604919,0.001329841,0.001461168,0.0003599431,0.003604468,0.0008933268],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004641066,"about_ca_system_score_gemma":0.0009348535,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005597152,"about_ca_topic_score_gemma":0.001002657,"domain_scores_codex":[0.9990498,0.0004523189,0.0001043843,0.0001219971,0.0001218129,0.0001496382],"domain_scores_gemma":[0.9986091,0.0004313647,0.0003391773,0.000146517,0.0001068677,0.0003669347],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9384692,0.01075264,0.002711733,0.0006599331,0.001995397,0.0001094418,0.00009773416,0.0005023986,0.009817949,0.00005761924,0.0006337267,0.0341923],"study_design_scores_gemma":[0.7707314,0.2072738,0.01642531,0.00004281346,0.001904266,0.0001649455,0.00007001304,0.0007400598,0.001884368,0.0001165277,0.0006004797,0.00004591572],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909936,0.006042785,0.0004551228,0.0002667857,0.0001717272,0.0005246316,0.0005989007,0.0001076242,0.0008389399],"genre_scores_gemma":[0.9934818,0.002587202,0.0006555503,0.0006739375,0.000316434,0.0005022131,0.0009097344,0.00002484374,0.0008483406],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004165257,"threshold_uncertainty_score":0.0138889,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02758072766961923,"score_gpt":0.3192333291753375,"score_spread":0.2916526015057183,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}